Toronto, ON, March 6, 2019 – Food Allergy Canada welcomes the recommendations and “foundational elements” included in the Implementation of National Pharmacare’s interim report released yesterday by Dr. Eric Hoskins and Ministers Bill Morneau and Ginette Pettipas Taylor. These measures, if adopted, will greatly benefit many individuals and families who have children with food allergies and who might not be able to afford an epinephrine auto-injector (e.g. EpiPen®, AUVI-Q®).
“Recommendations provided in this interim report are a positive sign that Canadians with food allergies may soon have one less worry: whether they will be able to afford life-saving epinephrine medication,” said Jennifer Gerdts, Executive Director of Food Allergy Canada. “We believe strongly that everyone who requires this medication should have access to it, regardless of price or ability to pay.”
Food allergies are a growing public health concern affecting more than 2.6 million Canadians. Given that even a small amount of an allergen, if ingested, could cause a serious allergic reaction and be potentially life-threatening, access to epinephrine auto injectors is essential…
Lesen Sie weiter auf: Food Allergy Canada welcomes Interim report from the Advisory Council on the Implementation of National Pharmacare
Quelle: Food Allergy Canada
Titelbild/Grafik by Food Allergy Canada
Kommentare und FragenMöchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von Food Allergy Canada